Supernus Pharmaceuticals Inc’s recently made public that its SVP, Chief Medical Officer Rubin Jonathan unloaded Company’s shares for reported $36292.0 on Feb 21 ’25. In the deal valued at $39.15 per share,927 shares were sold. As a result of this transaction, Rubin Jonathan now holds 7,853 shares worth roughly $0.29 million.
Then, Bhatt Padmanabh P. sold 9,477 shares, generating $376,237 in total proceeds. Upon selling the shares at $39.70, the Sr. VP of IP, CSO now owns 10,149 shares.
Before that, Bhatt Padmanabh P. sold 2,573 shares. Supernus Pharmaceuticals Inc shares valued at $101,942 were divested by the Sr. VP of IP, CSO at a price of $39.62 per share. As a result of the transaction, Bhatt Padmanabh P. now holds 10,149 shares, worth roughly $0.38 million.
Cantor Fitzgerald upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “a Neutral”. Cantor Fitzgerald began covering SUPN with “an Overweight” recommendation on January 06, 2025. Piper Sandler revised its rating on September 11, 2024. It rated SUPN as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of SUPN
On Tuesday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock jump 1.30% to $37.53. Over the last five days, the stock has gained 12.20%. Supernus Pharmaceuticals Inc shares have risen nearly 26.92% since the year began. Nevertheless, the stocks have risen 3.79% over the past one year.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-07-15, growing by 1.07 million shares to a total of 5.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.03 million shares. There was a rise of 20.96%, which implies that there is a positive sentiment for the stock.
